Most Recent Discussions

Sep 25 2020

Re: Rocklatan FDA Approved

Curious, I just started a patient (my first with this therapy) on Rocklatan after getting ZERO IOP change on generic Xalatan. He has been using it correctly for no more than two weeks but is complaining of bloodshot eyes. Is
read more

Jul 10 2018

Re: Longitudinal Study of Corneal Hysteresis

Great article, Jim, thanks.

Nov 27 2017

Re:

Clinician Topics

Glaucoma Watch: Interesting Glaucoma Cases; From Ocular Hypertension to Glaucoma: How to Predict Conversion; Neckties and IOP: The Controversy Continues; Introduction to the National Glaucoma Society; Case Presentation: Optic Nerve Imaging; NGS Residency Award and Lecture; Optic Nerve Head Measurements with the HRT III; Case Presentation: Laser Imaging Detects Early ON Damage; Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?; Interview with Dr. Barry Barresi; Glaucoma Continuum; Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study; The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older; Altered Nitric Oxide System in Patients with Open-Angle Glaucoma; Oxidative Stress in Glaucoma: A Burden of Evidence; Gonioscopy Videos; Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women; Programs to Optimize Adherence in Glaucoma; Corneal Hysteresis; Visual Field Interpretation; Study Questions link between Glaucoma and Alzheimer's Disease; Checking Color Vision; IOP Asymmetry as Glaucoma Risk Factor; Glaucoma Risk Calculators; Dr. David Calkins Discusses Catalyst for A Cure; Smart Phone Biosensor; Handheld OCT; Sustained Release IOP Therapies; Introduction to Corneal Hysteresis; FDT Perimetry; Visual Fields Overview; National Glaucoma Symposium 2017; Gonioscopy Slides from 2017 National Glaucoma Symposium; Measuring Corneal Hysteresis; XEN Glaucoma Implant Video; Corneal Hysteresis; Glaucoma Quality of Life Measures; Corneal Hysteresis: The A1C of Glaucoma; Predicting Progression; New Developments in Glaucoma Management; SECO Session on Innovations in Glaucoma; Longitudinal Study of Corneal Hysteresis; National Glaucoma Symposium 2018; DREAM Study; OIS at SECO; National Glaucoma Symposium Cape Cod; Is Glaucoma a Two-Pressure Disease?; ICD Stage Definitions; Visual Fields and Progression; OCT: The Basics; Co-Managing Glaucoma Surgery; Normal Tension Glaucoma; The Importance of Visual Fields; Corneal Hysteresis; Using OCT in Glaucoma Management; The LiGHT Study; Durysta Overview; Options in Glaucoma Surgery; Telemedicine in Glaucoma; Glaucoma Medications

In Your Office: Glaucoma Flowsheet; Tonometer Calibration; Pachymetry Coding; BCBS Coverage of SCODI Services; Expanded Coverage of Glaucoma Screening Services; Coding Update: 92135 Deleted and Replaced; ABO Certification Review Materials; Small Fee Reduction in CMS Payments in 2015; Moist Heat Compresses; Information about Omega-3s; Glaucoma Website for Patients; Beware of Phone Scam Posing as DPH or DEA; Tonography; Patient Assistance Programs

Pharmacology Update: Extravan: Alcon Pharmaceuticals; Mechanism of IOP Reduction with Travoprost; Hydroxychloroquine Toxicity; Timolol; Upneeq Drops for Ptosis

Clinical Guidelines: CCT: Is is time to say YES?; The Role of CCT in Glaucoma Patients; More CCT; The Paradox of IOP; Should We Treat All Ocular Hypertensives?; Beta Blockers in Glaucoma Management; Re-Defining Ocular Hypertension; Implications of Macro-Disc Asymmetry in Glaucoma Suspects; Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies; CyPass Clinical Recommendations

Industry News: New FDA Approval for Lumigan; Alcon's Travatan Z Solution Receives FDA Approval; Alcon's Travatan Z and Systane Use Different Preservatives; Pfizer Sponsors New "All Eyes on Glaucoma" Website; CLIA Waivers; Bausch + Lomb New Glaucoma Drug; Glaukos iStent inject FDA Approved; Alcon Withdraws CyPass Stents; Nuretin Omega-3 Supplements; Rocklatan FDA Approved; Vivid Vision Perimetry; Falck Multifunction Device

Upcoming Programs

December 2, 2020

Dr. Brian Mathie presents "Cannibis and the Eye" as a live webinar from 8:00-9:00 P.M. Eastern Time (7:00-8:00 PM. Central Time) on Wednesday, December 2.

December 9, 2020

Dr. Nate Lighthizer presents "OCT-A" as a live webinar from 8:00-9:00 P.M. Eastern Time (7:00-8:00 PM. Central Time) on Wednesday, December 9.

January 13, 2021

Dr. Mark Dunbar presents "Hot Topics in Retina" as a live webinar from 8:00-9:00 P.M. Eastern Time (7:00-8:00 PM. Central Time) on Wednesday, January 13.

January 27, 2021

Dr. Jim Thimons and Dr. Joseph Panarelli present "Surgical Advances in Glaucoma Therapy" as a live webinar from 8:00-9:00 P.M. Eastern Time (7:00-8:00 PM. Central Time) on Wednesday, January 27.

Your Registrations

You have no registrations currently in your cart.

News

CALIFORNIA ALLOWS LIVE WEBINARS AS LIVE CE

The California Board of Optometry now recognizes interactive courses offered live over internet platforms such as WebEx as Live CE toward the 30 hours of live continuing education required for license renewal. Courses can be live COPE courses offered by COPE's June 30, 2021 deadline or courses approved by the Board.

COPE EXTENDS RULES ON INTERACTIVE WEBINARS

Interactive webinars offered through June 30, 2021 will be classified as Live COPE Events. These webinars will not require a test. The NGS live webinars through June 2021 will be submitted to COPE for approval as Live COPE Events. Thus, the webinars will meet the criteria for CE in most states. States may consider these webinars as live or on-line CE. More information is included in the description of the webinars on the NGS website. Some State Boards are modifying restrictions for on-line CE because of COVID-19. Check the website of your State Board of Optometry for the latest rulings.

NEW FEATURE ON REGISTRATION PAGE

We have modified the registration page on the NGS website to eliminate duplicate registrations. If you try to register for a webinar for which you have already registered, the message "Already Registered" will appear on the page so you cannot add it to your cart. This should save time so that you do not go through the steps of registering again.

SEPTEMBER - DECEMBER WEBINARS APPROVED IN TEXAS

The NGS webinars in September through December have been approved by the Texas Board of Optometry as live CE. This includes the one-hour Wednesday webinars as well as the National Glaucoma Symposium East on September 12-13 and the National Glaucoma Symposium West on October 11.

MALVERN, PA PROGRAM CANCELLED FOR 2020

The National Glaucoma Society Regional Program Iin Malvern, PA will not be held in 2020, due to the restrictions on large groups and requirements for social distancing that we believe will continue through the fall because of the COVID-19 pandemic. Since both NJ and PA are allowing on-line CE during this renewal cycle, we invite you to participate in the NGS live webinars for your CE credit.

NGS 1-HOUR WEBINARS

The NGS will offer two webinars per month in September-December and January - May. These webinars are included in Full NGS Membership.

MA BOARD WAIVES LIMITS ON DISTANCE LEARNING

At its March 25 meeting, the Massachusetts Board of Optometry voted to waive the 6-hour limit on distance learning CE. For CE completed between January 1 and December 31, 2020, Massachusetts optometrists can obtain up to 18 hours of distance learning CE, provided the course is COPE approved, separately approved by the Board of Optometry, or offered by an organization specified in Massachusetts regulations as an approved entity. This policy will be posted to the Board's website soon, but is now in effect.

NGS LIVE WEBINARS = CATEGORY 1 ABO

We have received confirmation that the NGS live webinars now count as Category 1 Education towards American Board of Optometry (ABO) certification.

Join Our Email List

National Glaucoma Society